The tunable nature of phosphoramidate
linkers enables broad applicability
as pH-triggered controlled-release platforms, particularly in the
context of antibody- and small-molecule-drug conjugates (ADCs and
SMDCs), where there remains a need for new linker technology. Herein,
we explored in-depth the release of turn-on fluorogenic payloads from
a homoserinyl-based phosphoramidate acid-cleavable linker. Kinetics
of payload release from the scaffold was observed in buffers representing
the pH conditions of systemic circulation, early and late endosomes,
and lysosomes. It was found that payload release takes place in two
key consecutive steps: (1) P–N bond hydrolysis and (2) spacer
immolation. These two steps were found to follow pseudo-first-order
kinetics and had opposite dependencies on pH. P–N bond hydrolysis
increased with decreasing pH, while spacer immolation was most rapid
at physiological pH. Despite the contrasting release kinetics of these
two steps, maximal payload release was observed at the mildly acidic
pH (5.0–5.5), while minimal payload release occurred at physiological
pH. We integrated this phosphoramidate-payload linker system into
a PSMA-targeted fluorescent turn-on probe to study the intracellular
trafficking and release of a fluorescent payload in PSMA-expressing
prostate cancer cells. Results showed excellent turn-on and accumulation
of the coumarin payload in the late endosomal and lysosomal compartments
of these cells. The release properties of this linker mark it as an
attractive alternative in the modular design of ADCs and SMDCs, which
demand selective intracellular payload release triggered by the pH
changes that accompany intracellular trafficking.